2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
FDA Comment Number : EC3673
Submitter : Mrs. frances toth Date & Time: 12/19/2006 09:12:09
Organization : self
Category : Consumer Group
Issue Areas/Comments
GENERAL
GENERAL
i write to implore the fda to issue guidelines to pharmaceutical companiesthat, when manufacuring vaccines, they restrict the use of stem cells to those lines established from sources other than fetaltissue obtained fromaborted babies. it only makes sense to utilize non objectional cell lines in vaccine production, so that all people can benefit from them without compromising their moral beliefs and pro-life convictions. this is especially true since there is an abundance of ethical resources. in doing so the fda will make it clear that here in the united states, where the inalienable right to life is proclaimed in our declaration of independence, no persons life -no matter how young or how early - will be forfeited for the sake of others. sincerely frances toth.